Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.
about
Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Rationale and design of combin ...... chemic Stroke (FAMTAIS) trial.
@en
Rationale and design of combin ...... ctomy in Acute Ischemic Stroke
@nl
type
label
Rationale and design of combin ...... chemic Stroke (FAMTAIS) trial.
@en
Rationale and design of combin ...... ctomy in Acute Ischemic Stroke
@nl
prefLabel
Rationale and design of combin ...... chemic Stroke (FAMTAIS) trial.
@en
Rationale and design of combin ...... ctomy in Acute Ischemic Stroke
@nl
P2093
P2860
P356
P1476
Rationale and design of combin ...... chemic Stroke (FAMTAIS) trial.
@en
P2093
Bruce Campbell
Fu-Dong Shi
Longting Lin
Meixia Zhang
Ruiting Zhang
Sheng Zhang
P2860
P304
P356
10.1177/1747493017710340
P577
2017-01-01T00:00:00Z